• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • Sponsored Placement
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Advancement in Liquid Dosage Excipients (Parenteral & Transdermal)


News provided by

ReportBuyer

Jul 23, 2014, 12:58 ET

Share this article

Share this article


LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Advancement in Liquid Dosage Excipients (Parenteral & Transdermal)

https://www.reportbuyer.com/product/2244741/Advancement-in-Liquid-Dosage-Excipients-Parenteral--Transdermal.html

The Increasing Number of Therapeutic Drugs, Need for Immediate Relief Drive the Growth of Parenteral and Transdermal Excipients

This study covers in detail the parenteral and transdermal excipients used in the pharmaceutical industry. We have observed that the growing prescription of biologicals that are almost exclusively administered by parenteral routes drives the market growth. Convenience and immediate therapeutic benefits have spurred the growth of transdermal products, which has in-turn increased transdermal excipients. The benefits provided by both product forms are expected to gain market share in the next five years.

Executive Summary
-In 2013, the global parenteral excipients segment generated a revenue of $ million, and it is predicted to grow to become $ billion by the year 2018 with a CAGR of %.
-The total global parenteral finished products market is estimated to be worth $billion. Parenteral finished products include vials with sterile liquids or powders to be reconstituted for injection; prefilled syringes, cartridges, or pens; single-dosage vials; multiple-dosage vials; and infusion bottles.
-The transdermal excipients segment is predicted to generate $ million by 2018, growing at a CAGR of %. This market is currently generating a global revenue of $ million.
-The high growth of biological drugs that are exclusively administered only through the parenteral route is driving market growth.
oVial injections make up about % of all parenteral units prescribed globally, with the remainder composed of prefilled syringes and other forms such as cartridges, auto injectors, and pens. Diabetes takes the lion's share of more than % of injectable units.
-Usage of transdermal patches has recently increased multifold in developed regions such as the United States and Western Europe because of its convenience of use and sustained therapeutic effect. The growth of transdermal is accelerating the growth of transdermal excipients.
-The main restraint hindering market growth is increased cost of production, which is leading to high-priced parenteral and transdermal excipients. High price hinders the adaptation of the product by pharmaceutical companies.
-The key market participants in this market are BASF, Dow Chemicals, and Gattefosse. Other market participants include Cargill and Abitech.

Market Overview—Parenteral Excipients
Parenteral Drugs:
-Parenteral drugs are pyrogen-free, sterile liquid or solid dosages. They may contain or more active ingredients in the form of single as well as multiple dosages.
-These drugs are administered in the form of injections, intravenous infusions, or implants, and they tend to have improved bioavailability compared to oral solid dosages.
-The first-pass metabolism of a parenteral enhances its bioavailability.
-Excipients such as buffering agents, solubilizing agents, anti-microbial preservatives, and carbohydrate excipients are used exclusively in formulating parenteral drugs.
-Biologic parenterals was a $ billion market globally in 2011. About % of indications for biologic parenterals arise from prescriptions for inflammatory diseases, cancers, infectious diseases, and diabetes.
-The total global parenterals market was estimated to be worth $ billion in 2011. Products in this market can be classified as newer biopharmaceuticals that are almost exclusively available as parenterals and conventional injectables.
1. EXECUTIVE SUMMARY

Executive Summary
Research Scope and Methodology

2. MARKET OVERVIEW

Market Overview
Market Overview—Parenteral Excipients
Market Overview—Transdermal Excipients
Market Overview—Parenteral Excipient Types/Classification
Market Overview—Parenteral Excipient Functions
Market Overview—Transdermal Excipient Types/ Classification
Market Overview—Transdermal Excipients Functions
Advancement in Liquid Dosage Excipients—Value Chain

3. TOTAL TRANSDERMAL AND PARENTERAL MARKET—DRIVERS AND RESTRAINTS

Total Transdermal and Parenteral Market—Drivers and Restraints
Parenteral Excipients Segment—Drivers and Restraints
Drivers Explained
Restraints Explained
Transdermal Excipients Segment—Drivers and Restraints
Drivers Explained
Restraints Explained

4. TOTAL TRANSDERMAL AND PARENTERAL MARKET—FORECAST AND TRENDS

Total Transdermal and Parenteral Market—Forecast and Trends
Market Engineering Measurements
Total Transdermal and Parenteral Excipients Market—Revenue and Volume Forecast
Revenue and Volume Forecast Discussion
Parenteral Excipients Segment—Pricing by Product Type
Transdermal Excipients Segment—Pricing by Product Type
Transdermal and Parenteral Excipients Market—Pricing by Product Type Discussion

5. COMPETITIVE ANALYSIS

Competitive Analysis
Excipients for Parenteral Products—Suppliers
Excipients for Transdermal Products—Suppliers
Market Share Analysis—Ranking of Suppliers for Selected Excipients
Competitive Analysis—Excipients in Marketed Parenteral Products
Competitive Analysis—Excipients in Marketed Transdermal Products—Technology Overview
Transdermal and Parenteral Excipients Market—Competitive Factors
Transdermal and Parenteral Excipients Market—Competitive Factors Discussion
Company Profile of Key Market Participants—BASF
Company Profile of Key Market Participants—Dow Chemicals
Company Profile of Key Market Participants—Gattefosse

6. SEGMENT BREAKDOWN—PARENTERAL EXCIPIENTS

Segment Breakdown—Parenteral Excipients
Parenteral Excipients Segment Breakdown
Excipients for Parenteral Products
Excipients for Parenteral Products—Technology Overview
Parenteral Excipients Segment—Market Engineering Measurement
Parenteral Excipients Segment—Revenue and Volume Forecast
Revenue and Volume Forecast Discussion
Parenteral Excipients Segment—Percent Volume by Excipient Type
Percent Volume by Excipient Type Discussion

7. SEGMENT BREAKDOWN—TRANSDERMAL EXCIPIENTS

Segment Breakdown—Transdermal Excipients
Transdermal Excipients Segment Breakdown
Excipients for Transdermal Products—Technology Overview
Market Engineering Measurements—Transdermal Excipients Segment
Transdermal Excipients Segment—Revenue and Volume Forecast
Revenue and Volume Forecast Discussion
Transdermal Excipients Segment—Percent Volume by Excipient Type
Percent Volume by Excipient Type Discussion

8. REGIONAL BREAKDOWN—TRANSDERMAL AND PARENTERAL EXCIPIENTS MARKET

Regional Breakdown—Transdermal and Parenteral Excipients Market
Transdermal and Parenteral Excipients Market—Regional Breakdown
Transdermal and Parenteral Excipients Market—Regional Breakdown Discussion
Legal Disclaimer

9. THE FROST & SULLIVAN STORY

The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy


Read the full report:
Advancement in Liquid Dosage Excipients (Parenteral & Transdermal)

https://www.reportbuyer.com/product/2244741/Advancement-in-Liquid-Dosage-Excipients-Parenteral--Transdermal.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.